Incyte (INCY) Misses Q4 EPS by 76c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Incyte (INCY) PT Lowered to $87 at RBC Capital, 'Buyers on Weakness'
February 8, 2022 3:54 PM ESTRBC Capital analyst Brian Abrahams lowered the price target on Incyte (NASDAQ: INCY) to $87.00 (from $90.00) while maintaining an Outperform rating and said they would buy on weakness.
The analyst commented, "4Q featured strong initial launch metrics for Opzelura, solid sales for INCY's core MF... More
Mizuho Securities Reiterates Neutral Rating on Incyte (INCY)
February 8, 2022 7:53 AM ESTMizuho Securities analyst Mara Goldstein reiterated a Neutral rating and $95.00 price target on Incyte (NASDAQ: INCY) following the company's recent earnings report.
For an analyst ratings summary and ratings history on Incyte click here. For more ratings news on Incyte click here.
Shares of Incyte closed at $73.35 yesterday.
... More


